|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.10 EUR | -1.09% |
|
+0.74% | -9.06% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-05 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 472M 544M 442M 404M 762M 51.76B 774M 5.17B 2.03B 25.94B 2.04B 2B 86.22B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 424M 489M 397M 363M 685M 46.51B 695M 4.65B 1.82B 23.31B 1.84B 1.8B 77.49B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 day | -1.09% | ||
| 1 week | +0.74% | ||
| Current month | +0.74% | ||
| 1 month | -4.58% | ||
| 3 months | -1.81% | ||
| 6 months | -6.87% | ||
| Current year | -9.06% |
| 1 week | 26.9 | 27.4 | |
| 1 month | 26.2 | 27.4 | |
| Current year | 24.6 | 30.25 | |
| 1 year | 20.65 | 31.35 | |
| 3 years | 20.65 | 56.6 | |
| 5 years | 20.65 | 56.6 | |
| 10 years | 20.65 | 92.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.09% | +0.74% | - | - | 551M | ||
| -0.41% | -2.31% | -9.77% | -6.39% | 13.45B | ||
| -0.74% | +0.09% | +4.26% | +7.27% | 5.13B | ||
| -1.00% | -4.06% | -32.76% | -54.85% | 5.09B | ||
| -1.09% | -2.75% | -0.61% | -33.98% | 4.07B | ||
| -1.15% | -3.23% | -8.42% | -5.22% | 3.7B | ||
| +3.32% | +0.63% | +0.56% | +8.14% | 3.58B | ||
| -1.46% | -2.88% | -6.35% | +11.28% | 3.48B | ||
| -1.47% | -1.28% | -16.05% | -24.25% | 2.45B | ||
| -1.25% | -4.06% | -4.44% | +47.93% | 1.87B | ||
| Average | -0.63% | -3.02% | -8.18% | -5.56% | 4.76B | |
| Weighted average by Cap. | -0.53% | -3.32% | -8.82% | -9.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 562M 456M 418M 787M 53.43B 799M 5.34B 2.1B 26.78B 2.11B 2.06B 89.02B | 501M 577M 469M 429M 809M 54.92B 821M 5.49B 2.15B 27.53B 2.17B 2.12B 91.49B |
| Net income | 11.34M 13.06M 10.61M 9.71M 18.3M 1.24B 18.58M 124M 48.72M 623M 49.03M 47.96M 2.07B | 32.64M 37.61M 30.56M 27.96M 52.7M 3.58B 53.49M 358M 140M 1.79B 141M 138M 5.96B |
| Net Debt | -49.74M -57.31M -46.57M -42.6M -80.31M -5.45B -81.51M -545M -214M -2.73B -215M -210M -9.08B | -47.86M -55.14M -44.81M -40.99M -77.27M -5.24B -78.42M -524M -206M -2.63B -207M -202M -8.74B |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change |
|---|---|---|
| 26-08-06 | €27.10 | -1.09% |
| 26-08-05 | €27.40 | 0.00% |
| 26-08-04 | €27.40 | +1.48% |
| 26-08-03 | €27.00 | +0.37% |
| 26-07-31 | €26.90 | -0.37% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BON Stock
Select your edition
All financial news and data tailored to specific country editions
















